Who is sponsoring NCT03567811?

NCT03567811 is sponsored by Georgetown University.

What drugs are being tested in NCT03567811?

Interventions in NCT03567811: Submaximal bicycle exercise stress test on Days 1 and 2.

What condition does NCT03567811 study?

NCT03567811 studies Chronic Fatigue Syndrome.

Is NCT03567811 still recruiting?

NCT03567811 is currently completed. Last updated 20 June 2019.

Last reviewed 2019-06-20 · How we verify

NCT03567811

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exertional Exhaustion in Chronic Fatigue Syndrome

Completed NA Last updated 20 June 2019

What this trial tests

NA trial testing Submaximal bicycle exercise stress test on Days 1 and 2 in Chronic Fatigue Syndrome in 72 participants. Completed in 31 July 2018.

Timeline

1 August 2013

Primary endpoint
31 July 2018

31 July 2018

Quick facts

Lead sponsor	Georgetown University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	72
Start date	1 August 2013
Primary completion	31 July 2018
Estimated completion	31 July 2018

Drugs / interventions tested

Submaximal bicycle exercise stress test on Days 1 and 2

Conditions studied

Chronic Fatigue Syndrome — all drugs for Chronic Fatigue Syndrome →

Sponsor

Georgetown University

Who can join

18 and older, any sex, with Chronic Fatigue Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Post-exertional malaise was modeled by having Chronic Fatigue Syndrome (CFS) and sedentary control subjects perform submaximal exercise on 2 consecutive days with objective changes in brain function measured by magnetic resonance imaging (MRI) during cognitive tests before and after the 2 exercise sessions.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Orthostatic intolerance in chronic fatigue syndrome.
Garner R, Baraniuk JN. · · 2019 · cited 25× · PMID 31159884 · DOI 10.1186/s12967-019-1935-y
A Machine Learning Approach to the Differentiation of Functional Magnetic Resonance Imaging Data of Chronic Fatigue Syndrome (CFS) From a Sedentary Control.
Provenzano D, Washington SD, Baraniuk JN. · · 2020 · cited 14× · PMID 32063839 · DOI 10.3389/fncom.2020.00002
Machine Learning Detects Pattern of Differences in Functional Magnetic Resonance Imaging (fMRI) Data between Chronic Fatigue Syndrome (CFS) and Gulf War Illness (GWI).
Provenzano D, Washington SD, Rao YJ, Loew M, et al · · 2020 · cited 9× · PMID 32708912 · DOI 10.3390/brainsci10070456
Cerebrospinal fluid metabolomics, lipidomics and serine pathway dysfunction in myalgic encephalomyelitis/chronic fatigue syndroome (ME/CFS).
Baraniuk JN. · · 2025 · cited 4× · PMID 40025157 · DOI 10.1038/s41598-025-91324-1
Exertional Exhaustion (Post-Exertional Malaise, PEM) Evaluated by the Effects of Exercise on Cerebrospinal Fluid Metabolomics-Lipidomics and Serine Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Baraniuk JN. · · 2025 · cited 4× · PMID 39941050 · DOI 10.3390/ijms26031282

Verify or expand the search:

Other recruiting trials for Chronic Fatigue Syndrome

Currently open trials in the same condition.

NCT07009691 — Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS · NA · recruiting
NCT06585254 — tVNS in Long COVID-19 · NA · recruiting
NCT05741112 — The Long COVID-19 Wearable Device Study · NA · recruiting
NCT05967052 — Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitati · Phase 2 · recruiting
NCT05525598 — Internet-based Treatment for Patients Suffering From Severe Functional Somatic Disorders · NA · recruiting

Other Georgetown University trials

Trials by the same sponsor.

NCT07228000 — Bundled Cancer Screening and Genetic Services Navigation · NA · not yet recruiting
NCT07128927 — Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors · NA · recruiting
NCT06046287 — Daratumumab for Polyneuropathy Associated With MGUS · Phase 2 · withdrawn
NCT06980103 — Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyro · NA · recruiting
NCT07105358 — Visual Plasticity Following Brain Lesions · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03567811 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Georgetown University
Last refreshed: 20 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03567811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing